Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic testing, Alzheimer disease, and long-term care insurance.

Genetic testing - 1 Jan 1999

Fogarty M

Abstract excerpt

Patients with Alzheimer Disease (AD) often need long-term care, which is poorly covered by private or governmental health insurance. Private long-term care (LTC) insurance is increasingly being marketed to provide some financial support for long term care. LTC insurance does cover AD, but the ins...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Cost of Illness
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Long-Term Care

Source

Identifiers

PMID: 10464587
DOI: 10.1089/gte.1999.3.133

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-10464587-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic testing, Alzheimer disease, and long-term care insurance.PMID 10464587Read ↗

Genetic testing and Alzheimer disease: recommendations of the Stanford Program in Genomics, Ethics, and Society.Semantic proximity Read ↗

Genetic testing and Alzheimer disease: has the time come? Alzheimer Disease Working Group of the Stanford Program in Genomics, Ethics & Society.Semantic proximity Read ↗

Genetic testing and Alzheimer disease: the promise.Semantic proximity Read ↗

Genetic testing for neurodegenerative diseases: Ethical and health communication challenges.Semantic proximity Read ↗

Advances in genetic testing for Alzheimer's disease.Semantic proximity Read ↗

Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues.Semantic proximity Read ↗

Genetic testing has no place as a routine diagnostic test in sporadic and familial cases of Alzheimer's disease.Semantic proximity Read ↗

Ethical, Legal and Social Implications of Susceptibility Genetic Testing for Late-Onset Neurodegenerative DiseasesSemantic proximity Read ↗

To know or not to know: an update of the literature on the psychological and behavioral impact of genetic testing for Alzheimer disease risk.Semantic proximity Read ↗

Recommendations for genetic counseling for individuals at risk of autosomal dominant Alzheimer's disease in Latin America.Semantic proximity Read ↗

I Had Genetic Testing for Alzheimer's Disease Without My Consent.Semantic proximity Read ↗

Medicolegal, employment, and insurance issues in APOE genotyping and Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.